The company maintains a record of 43 consecutive years of dividend increases, supported by strong capital and cash flows. Aflac pursues growth through diversifying its product range to meet changing customer needs, with estimated revenue growth of 5-7% annually through 2027.
Cyborg Score Rationale
Aflac reported Q4 2025 revenue of $4.87 billion, up 12.7% year-over-year and exceeding Wall Street estimates by 10.5%. Book value per share grew 22.3% annually over the last two years, though challenged by long-term growth headwinds and recent cybersecurity incident.
Top Insights
Japan segment delivered 15.7% sales increase driven by new cancer and medical products
Book value per share accelerated to 22.3% annual growth over two years, reaching $56.85 per share
43 consecutive years of dividend increases reflect sustainable capital generation
Company addressed network security incident initially disclosed in June 2025
Named Competitors
MetLife — Leading insurance company with 12% market share
Prudential Financial — Major diversified financial services provider
Cigna — Health services and insurance provider
Recent Developments
(November 2025) Announced 5.2% dividend increase to $0.61 per share for Q1 2026